Hypofraction Radiotherapy for Limited-Stage Small Cell Lung Cancer

计划入组 40 人 · 首次发布于 2022 年 9 月 1 日

Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer

计划入组 2 人 · 首次发布于 2009 年 5 月 22 日

Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01)

计划入组 58 人 · 首次发布于 2024 年 4 月 17 日

Durvalumab(Imfinzi)

GSK-2302032A

YTHDC1 inhibitor (small cell lung cancer)

ADDARIO LUNG CANCER MEDICAL INSTITUTE

United States

European Lung Cancer Working Party

Belgium

WAI LUNG HONG AGRIBUSINESS LIMITED

Hong Kong, China

NICE Approves Durvalumab for Limited-Stage Small Cell Lung Cancer, First Treatment Advance in Over 30 Years

Imfinzi Approved for Limited-Stage Small Cell Lung Cancer, Redefining Treatment

FDA Grants Priority Review and Breakthrough Therapy Designation to Imfinzi for Limited-Stage Small Cell Lung Cancer